NextPlat (NXPL) Interest Expenses (2015 - 2025)
NextPlat's (NXPL) quarterly Interest Expenses came in at $17000.0 in Q4 2025, down 10.53% year-over-year from $19000.0 in Q4 2024, and up 21.43% quarter-over-quarter from $14000.0 in Q3 2025.
Powered by 
Analysis
NextPlat (NXPL) Interest Expenses (2015 - 2025) Analysis & Trends
NextPlat (NXPL) has reported Interest Expenses for 11 consecutive years, with $17000.0 the latest figure, recorded in Q4 2025.
- On a quarterly basis, Interest Expenses fell 10.53% year-over-year to $17000.0 in Q4 2025; TTM through Dec 2025 was $64000.0, a 20.99% decrease from a year earlier, with the FY2025 full-year figure at $64000.0, down 20.99% from the prior year.
- Interest Expenses was $17000.0 for Q4 2025 at NextPlat, up from $14000.0 in the prior quarter.
- Over five years, Interest Expenses peaked at $940907.0 in Q2 2021 and troughed at $2385.0 in Q3 2021.
- A 5-year average of $85765.0 and a median of $16000.0 in 2025 frame the typical range for Interest Expenses.
- The widest YoY moves for Interest Expenses: up 1345.46% in 2021, down 99.63% in 2021.
- Over 5 years, Interest Expenses stood at $3314.0 in 2021, then surged by 151.99% to $8351.0 in 2022, then jumped by 175.42% to $23000.0 in 2023, then fell by 17.39% to $19000.0 in 2024, then retreated by 10.53% to $17000.0 in 2025.
- The last three Interest Expenses figures came in at $17000.0 (Q4 2025), $14000.0 (Q3 2025), and $15000.0 (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | 120.70 Mn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | -13.26 Mn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 396.00 Mn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | - |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | -41.02 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 6.66 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | 3,000.00 |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 17,000.00 |
| Sep 30, 2025 | 14,000.00 |
| Jun 30, 2025 | 15,000.00 |
| Mar 31, 2025 | 18,000.00 |
| Dec 31, 2024 | 19,000.00 |
| Sep 30, 2024 | 22,000.00 |
| Jun 30, 2024 | 19,000.00 |
| Mar 31, 2024 | 21,000.00 |
| Dec 31, 2023 | 23,000.00 |
| Sep 30, 2023 | 46,000.00 |
| Jun 30, 2023 | 5,000.00 |
| Mar 31, 2023 | 5,000.00 |
| Dec 31, 2022 | 8,351.00 |
| Sep 30, 2022 | 8,725.00 |
| Jun 30, 2022 | 3,681.00 |
| Mar 31, 2022 | 3,243.00 |
| Dec 31, 2021 | 3,314.00 |
| Sep 30, 2021 | 2,385.00 |
| Jun 30, 2021 | 940,907.00 |
| Mar 31, 2021 | 520,694.00 |